Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 5413-5416

  De Haan, Lolke ^a   Verweij, Willem R ^a   Feil, Ingeborg K ^b   Lijnema, Tineke H ^a   Hol, Wim G J ^b   Agsteribbe, Etienne ^a   Wilschut, Jan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL;

EID: 0029805948     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.5413-5416.1996     Document Type: Article

References (27)

1. 5 ADP-ribosylating toxins: comparative anatomy and physiology. Structure 2:151-158.
2. Clemens, J., D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, M. R. Rao, M. R. Kahn, M. Yunus, N. Huda et al. 1990. Field trial of oral cholera vaccines in Bangladesh: results from a three-year follow-up. Lancet 335:2711-273,
3. Clements, J. D., N. M. Hartzog, and F. L. Lyon. 1988. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 6:269-277.
4. DeHaan, A., H. J. Geerligs, J. P. Huchshorn, G. J. M. van Scharrenburg, A. M. Pulache, and J. Wilschut. 1995. Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine 13:155-162.
5. DeHaan, L., W. R. Verweij, M. Holtrop, E. Agsteribbe, and J. Wilschut. 1996. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit. Vaccine 14:620-626
6. Dertzbaugh, M. T., and C. O. Elson. 1993. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptidc addition. Infect, Immun, 61:384-390.
7. Dickinson, U. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617-1623.
8. Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoll, G. Dougan, S. Abrignani, G. Douce, and M. T. De Magistris. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979.
9. Douce, G., C. Turcotte, I. Cropley, M. Roberts, M. Pizza, M. Domenghini, R. Rappuoli, and G. Dougan. 1995. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic. mucosal adjuvants. Proc. Nutl, Acad. Sci. USA 92:1644-1648.
10. Elson, C. O., and W. Ealdling. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2741.
11. Feil, I. K., R. Reddy, L De Haan, E. A. Merritt, F. Van de Akker, D. R. Storm, and W. G. J. Hol. 1996. Protein engineering studies indicate the crucial importance of the A chain loop 47 to 56 for cytotoxicity of E. coli heat-labile enterotoxin. Mol. Microbiol. 20:823-832.
12. Fontana, M. R., R. Manetti, V. Glannelli, C. Magagnoli, A. Marchini, R. Ollvieri, M. Domenighini, R. Rappuoll, and M. Pizza. 1995. Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit. Infect. Immun. 63:2356-2360.
13. Holmgren, J., N. Lycke, and C, Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11:1179-1184.
14. Kazemi, M., and R. A. Finkelstein. 1991. Mapping epitopic regions of cholera toxin B-subunit protein. Mol. Immunol. 28:865-876
15. Levine, M. M., and J. B. Kaper. 1993. Live oral vaccines against cholera: an update. Vaccine 11:207-212.
16. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Escherichia cali heat-labile enterotoxins is linked to their ADPribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
17. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal Immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
18. Meissner, P. S., W. P. Sisk, and M. L. Berman. 1987. Bacteriophage lambda cloning system for the construction of directional cDNA libraries. Proc. Natl. Acad. Sci. USA 84:4171-4175.
19. Moss, J., S. J. Stanley, M. Vaughan, and T. Tsuji. 1993. Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution. J. Biol. Chem. 268:6383-6387.
20. Peterson, A., D. E. Hejtmancik, D. E. Markel, J. P. Cralg, and A. Kurosky. 1979. Antigenic specificity of neutralizing antibody to cholera toxin. Infect. Immun. 24:774-781.
21. Pizza, M., M. R. Fontana, M. M. Giuliani, M. Domenighini, C. Magagnoli, V. Glannelli, D. Nucci, W. G. J. Hol, R. Manetti, and R. Rappuoli. 1994. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med. 180: 2147-2153.
22. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647.
23. Tsuji, T., T. Inoue, A. Miyama, K. Okamoto, T. Honda, and T. Miwatani. 1990. A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in loss of its toxic activity. J. Biol. Chem. 265:22520-22525.
24. Uesaka, Y., Y. Otsuka, Z. Lin, S. Yamasaki, J. Yamaoka, H. Kurazono, and V. Takeda. 1994. Simple method of purification of Escherichia coli heat-labile enterotoxin and cholera toxin using immobilized galactose. Microb. Pathog. 16:71-76.
25. VanderLlnden, M. P. G., H. Mottl, and W. Keck. 1992. Cytoplasmic high level expression of a soluble, enzymatically active form of the Escherichia coli penicillin-binding protein 5 and purification by dye chromatography. Eur. J. Biochem. 204:197-202.
26. Wilson, A. D., C. J. Clarke, and C. R. Stokes. 1990. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin. Scand. J. Immunol. 31:443-451.
27. Wong, Y. H., A. Federman, A. M. Pace, I. Zachary, T. Evans, J. Ponyssegur, and H. R. Bourne. 1991. Mutant alpha suhunits of Gi2 inhibit cAMP accumulation. J. Biol. Chem. 351:63-65.